Jeena Sikho Lifecare Board of Directors
Get the latest insights into the leadership at Jeena Sikho Lifecare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Manish Grover | Managing Director |
| Mrs. Bhavna Grover | Whole Time Director |
| Ms. Shreya Grover | Director |
| Mr. Chandan Kumar Kaushal | Independent Director |
| Mr. Karan Vir Bindra | Independent Director |
Jeena Sikho Lifecare Share price
JSLL
779.15
20.80 (2.74%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:45 IST
BUYSELL
Today's High
789.10
Today's Low
759.75
52 Week Low
400.25
52 Week High
2498.60
The current prices are delayed, login to your account for live prices
LoginJeena Sikho Lifecare FAQs
The board at Jeena Sikho Lifecare consists of experienced professionals, including Mr. Manish Grover , Mrs. Bhavna Grover , and others, overseeing the company’s strategic and corporate governance.
Directors at Jeena Sikho Lifecare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Manish Grover is the current chairman at Jeena Sikho Lifecare.
Executive directors at Jeena Sikho Lifecare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Jeena Sikho Lifecare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Jeena Sikho Lifecare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.